TEST:

UroAmp

UroAmp is a non-invasive genomic urine test that can reliably detect, monitor, and predict the risk of urothelial cancer or its recurrence months or even years before signs and symptoms develop or become detectable by cystoscopy. The test enables the generation of a comprehensive genomic profile that deeply interrogates 60 of the most high-impact urothelial cancer genes while broadly measuring changes across the whole genome. Each UroAmp report provides a unique fingerprint of the patient’s cancer or cancer risk. These actionable insights enable unique data-driven decision-making that can better anticipate, monitor and personalize the care management of the patients.